Pharmacologic treatment of lower urinary tract dysfunction in geriatric patients

American Journal of the Medical Sciences

Volumn 314, Issue 4, 1997, Pages 262-267

  Goode, Patricia S ^a   Burgio, Kathryn L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Geriatric; Nocturia; Pharmacologic treatment; Urinary incontinence

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESMOPRESSIN; DICYCLOVERINE; DIURETIC AGENT; DOXAZOSIN; ESTROGEN; HYOSCYAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; PRAZOSIN; PROPANTHELINE BROMIDE; TERAZOSIN; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; BEHAVIOR THERAPY; BLADDER CAPACITY; BLADDER CONTRACTION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; DETRUSOR DYSSYNERGIA; GERIATRIC PATIENT; HUMAN; NOCTURIA; NOCTURNAL ENURESIS; POLYURIA; PRACTICE GUIDELINE; RESIDUAL URINE; SIDE EFFECT; STRESS INCONTINENCE; TREATMENT OUTCOME; URGE INCONTINENCE; URINARY TRACT DISEASE; URINE INCONTINENCE;

EID: 0030820377     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199710000-00010     Document Type: Conference Paper

References (41)

1. Ouslander JG, Greengold B, Chen S. External catheter use and urinary tract infections among incontinent male nursing home patients. J Am Geriatr Soc. 1987;35:1063-70.
2. Resnick NM, Yalla SV. Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients. JAMA. 1987; 257:3076-81.
3. Hilton P, Stanton SL. The use of intravaginal oestrogen cream in genuine stress incontinence. Br J Obstet Gynaecol. 1983;99:940-4.
4. Burgio KL, Locher JL, Ives DG, Hardin JM, Newman AB, Kuller LH. Nocturnal enuresis in community-dwelling older adults. J Am Geriatr Soc. 1996:44:139-43.
5. Kirkland JL, Lye M, Levy DW, Banerjee AK. Patterns of urine flow and electrolyte excretion in healthy elderly people. BMJ. 1983;287:1665-7.
6. Pedersen PA, Johansen PB. Prophylactic treatment of adult nocturia with bumetanide. Br J Urol. 1988;62:145-7.
7. Wein AJ. Practical uropharmacology. Urol Clin N Am. 1991;18(2):269-81.
8. Finkbeiner A, Welch L, Bissada N. Uropharmacology IX: Direct acting smooth muscle stimulant and depressants. Urology. 1978;12:231-9.
9. Holmes DM, Montz FJ, Stanton SL. Oxybutynin versus propantheline in the management of detrusor instability: A patient-regulated variable dose trial. Br J Obstet Gynaecol. 1989;96:607-12.
10. Moore KH, Hay DM, Imrie AE, Watson A, Goldstein M. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability. Br J Urol. 1990;66:479-85.
11. Tapp AJ, Cardozo LD, Versi E and Cooper D. The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: A double-blind placebo controlled study. Br J Obstet Gynaecol. 1990;97:521-6.
12. Zeegers AGM, Kiesswetter H, Kramer AEJL, Jonas U. Conservative therapy of frequency, urgency and urge incontinence: A double-blind clinical trial of flavoxate hydrochloride, oxybutynin chloride, emepronium bromide and placebo. World J Urol. 1987;5:57-61.
13. Thuroff JW, Bunke B, Ebner A, Faber P, de Geeter P, Hannappel J, et al. Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivitiy: Oxybutynin versus propantheline versus placebo. J Urol. 1991;145:813-7.
14. Clarke B. Anticholinergic medication for the unstable bladder: Prospective trials of imipramine/propantheline versus penthienate and oxybutynin versus penthienate. Int Urogynecol J. 1996;7:191-5.
15. Meyhoff HH, Gerstenberg TC, Nordling J. Placebo - The drug of choice in female motor urge incontinence? Br J Urol. 1983;55:34-7.
16. Robinson JM, Brocklehurst JC. Emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence associated with detrusor instability in elderly women. Br J Urol. 1983;55:371-6.
17. Chapple CR, Parkhouse H, Gardener C, Milroy EJ. Double-blind, placebo-controlled, crossover study of flavoxate in the treatment of idiopathic detrusor instability. Br J Urol. 1990;66:491-4.
18. Milner G, Hills NF. A double-blind assessment of antidepressants in the treatment of 212 enuretic patients. Med J Aust. 1968;1:943-7.
19. Lose G, Jorgensen L, Thunedborg P. Doxepin in the treatment of female detrusor over-activity: A randomized double-blind crossover study. J Urol. 1989;142:1024-6.
20. Castelden CM, Duffin HM, Gulati RS. Double-blind study of imipramine and placebo for incontinence due to bladder instability. Age Ageing. 1986;15:299-303.
21. Cardozo LD, Stanton SL. An objective comparison of the effects of parenterally administered drugs in patients suffering from detrusor instability. J Urol. 1979;122:58-9.
22. Cardozo LD, Stanton SL, Robinson H, Holer D. Evaluation of flurbiprofen in detrusor instability. BMJ. 1980; 280:281-2.
23. Fantl JA, Newman DK, Colling J, DeLancey JOL, Keeys C, Loughery R, et al. Urinary Incontinence in Adults: Acute and Chronic Management. Clinical Practice Guideline, No. 2, 1996 Update. Rockville, MD: US Department of Health and Human Services; March 1996. Public Health Service, Agency for Health Care Policy and Research Publication 96-0682.
24. Lindholm P, Lose G. Terbutaline (Bricanyl) in the treatment of female urge incontinence. Urol Int. 1986;41:158-60.
25. Walter S, Walf H, Barlebo H, Jensen H. Urinary continence in postmenopausal women treated with oestrogens: A double-blind clinical trial. Urol Int. 1978;33:135-143.
26. Collste L, Lindskog M. Phenylpropanolamine in treatment of female stress urinary incontinence: A double-blind placebo-controlled study in 24 patients. Urodynamics. 1987;30:398-403.
27. Fossberg E, Beistand HO, Lundgren RA. Stress incontinence in females: Treatment with phenylpropanolamine: A urodynamic and pharmacological evaluation. Urol Int. 1983;38:293-9.
28. Lehtonen T, Rannikko S, Lindell O, Talja M, Wuokko E, Lindskog M. The effect of phenylpropanolamine on female stress urinary incontinence. Ann Chir Gynaecol. 1986; 75:236-41.
29. Andersson KE. Current concepts in the treatment of disorders of micturition. Drugs. 1988;35:477-94.
30. Walter S, Kjaergaard B, Lose G, Andersen JT, Heisterberg L, Jakobsen H, et al. Stress urinary incontinence in postmenopausal women treated with oral estrogen (estriol) and an alpha-adrenoceptor-stimulating agent (phenylpropanolamine): A randomized double-blind placebo-controlled study. Int Urogynecol J. 1990;1:74-9.
31. Wells TJ, Brink CA, Diokno AD, Wolfe R and Gillis GL. Pelvic muscle exercise for stress urinary incontinence in elderly women. J Am Geriatr Soc. 1991;39:785-91.
32. Beck RA, Mercado DL, Seguin SM, Andrade WP, Cushner HM. Cardiovascular effects of pseudoephedrine in medically controlled hypertensive patients. Arch Intern Med. 1992;152:1242-5.
33. Yasuda K, Kawabe K, Takimoto Y, Kondo A, Takaki R, Imabayashi K. A double-blind clinical trial of a β2-adrenergic agonist in stress incontinence. Int Urogynecol J. 1993;4:146-51.
34. Samsioe G, Jansson I, Mellstrom D and Svanborg A. Occurrence, nature and treatment of urinary incontinence in a 70-year-old female population. Maturitas. 1985;7:335-42.
35. Judge TG. The use of quinestradol in elderly incontinent women, a preliminary report. Gerontol Clin. 1969;11:159-64.
36. Fantl JA, Cardozo L, McClish DK, Hormones and Urogenital Therapy Committee. Estrogen therapy in the management of urinary incontinence in postmenopausal women: A meta-analysis: First report of the hormones and urogenital therapy committee. Obstet Gynecol. 1994;83:12-8.
37. Fantl JA, Bump RC, Robinson D, McClish DK, Wyman JF, Continence Program for Women Research Group. Efficacy of estrogen supplementation in the treatment of urinary incontinence. Obstet Gyn. 1996;88:745-9.
38. Benness C, Abbott D, Cardozo L, Cutner A, Whitehead M. Do progestogens exacerbate urinary incontinence in women on HRT? Neurourol Urodyn. 1991;10:316-7.
39. Resnick NM, Blaivas JG, Ostergard DR. Practical pointers on urinary incontinence. Patient Care. 1995;29:103-31.
40. Ek A, Andersson KE, Gullberg B, Ulmsten U. Effects of oestradiol and combined norephedrine and oestradiol treatment of female stress incontinence. Zentralbl Gynakol. 1980;102:839-44.
41. Ouslander JG, Schnelle JF, Uman G, Fingold S, Migam JG, Tuico E, et al. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial. J Am Geriatr Soc. 1995;43:610-7.